In this study, an up-regulation of serine/arginine-rich splicing factor 7 (SRSF7) was identified in lung fibroblasts derived from IPF patients and a bleomycin (BLM)-induced mouse model, and further ...

The primary measure of ILD progression was a decline in forced vital capacity (FVC) of 5% or more between annual visits.

With this landmark complex surgery, two patients have now successfully undergone robotic lung transplants, marking a major ...

After moving to Rotonda West, Bouyea and his wife Laura faced significant damage to their dream home due to Hurricane Ian.

Exposure to a common fungal molecule can reprogram immune cells in the lungs, causing them to overreact to infection-like ...

In this randomized controlled trial, treatment with nerandomilast led to slower declines in forced vital capacity (FVC) in patients with progressive pulmonary fibrosis over 52 weeks 2. The occurrence ...

According to data from the Health Insurance Review and Assessment Service in 2023, there are an estimated 15,000 patients ...

The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...

A 79-year-old man with recurrent oropharyngeal cancer has developed the first documented case of severe drug-induced interstitial lung disease following photoimmunotherapy with cetuximab-sarotalocan ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Dizal's oral EGFR inhibitor Zegfrovy (sunvozertinib) as a treatment for patients with locally advanced or ...